Clinical Trials Browser

INDUSTRY × Recurrence × Letrozole × Clear all

NCT06760637 2026-05-19

FourLight-3

Phase 3 Active not recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

NCT06570031 2025-07-02

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT00171808 2016-11-18

deFEND

Phase 2 Completed

Recurrence, Endometrial Neoplasms

NCT00333086 2012-04-19

A Study of Letrozole in the Treatment of Endometrial Cancer

Phase 2 Completed

Recurrence, Endometrial Neoplasms